徐建民-出血性疾病1

上传人:工**** 文档编号:592003405 上传时间:2024-09-19 格式:PPT 页数:27 大小:486.50KB
返回 下载 相关 举报
徐建民-出血性疾病1_第1页
第1页 / 共27页
徐建民-出血性疾病1_第2页
第2页 / 共27页
徐建民-出血性疾病1_第3页
第3页 / 共27页
徐建民-出血性疾病1_第4页
第4页 / 共27页
徐建民-出血性疾病1_第5页
第5页 / 共27页
点击查看更多>>
资源描述

《徐建民-出血性疾病1》由会员分享,可在线阅读,更多相关《徐建民-出血性疾病1(27页珍藏版)》请在金锄头文库上搜索。

1、DISORDERS OF HEMOSTASIS Dept.of Hematology ZhongShan Hospital,FuDan University Prof. JlAN-MIN XU General Considerations Disorders of hemostasis defects in platelet number or function problems in fibrin clot (coagulation)Bleeding due to platelet disorders is typically mucosal or dermatologic include

2、epistaxis, gum bleeding, menorrhagia, gastrointestinal bleeding, purpura, and petechiae General ConsiderationsPetechiae are seen almost exclusively in conditions of thrombocytopenia and not platelet dysfunction. Bleeding due to coagulopathy may occur as deep muscle hematomas as well as skin bleeding

3、. Spontaneous hemarthroses are seen only in severe hemophilia. General ConsiderationsDefinition: disorder of hemostasis spontaneous bleeding abnormal bleeding following trauma Machanism : vessel wall defect thrombocytopenia, platelet disfunction coagulation disorderNormal hemostasis and coagulation

4、hemostasis:1. Vessel wall:(1)vessel spasm: reflex spasm S-HT slow down blood flow(2)subendothelial connective tissue: encouraging platelet adhesion, activation, aggregation(3)releasing TF, activating F: triggering intrinsic and extrinsic pathway (4)pression of haematomaNormal hemostasis and coagulat

5、ion2. platelet:(1)adhesion: to subendothelial connective tissue by GPb、vWF(2)aggregation : formation of platelet thrombus by GPb/a(3)release: phosphatide-Arachidonic Acid -TXA2 further platelet activation and adhesion violent vessel spasmNormal hemostasis and coagulation3.coagulation:(1) Rearrangeme

6、nt of platelet membrane phosphatidate-PF3 (2) Tissue injury- TF release(3) Subendothelial connective tissue-a triggering intrinsic and extrinsic pathway-white thrombus-red thrombusNormal hemostasis and coagulationcoagulation:1.nature: a cascade of enzymes activation not active before ponent:1.12 coa

7、gulation factor: 11 in plasma (tissue factor) protein ( exclude Ca+ ) code with 、 etc.2.2.PKPK3.3.HMWKHMWKNormal hemostasis and coagulation3. course:(1)thromboplatin intrinsic: -a-a- a+Ca+PF3 extrinsic: III-VII+Ca -a+Ca+PF3(2)thrombin:prothrombinthromboplatin+CathrombinBoneu et al. Sang Thrombose Va

8、isseaux. 1998;10:291-313.IIVIIa细胞细胞的促的促凝血酶凝血酶原激酶原激酶Ca2+XaXIa内源性系统内源性系统内源性系统内源性系统外源性系统外源性系统外源性系统外源性系统XIXXIIIaXIXIIXIIa溶解溶解性性纤维蛋白纤维蛋白纤维蛋白纤维蛋白原原纤维蛋白纤维蛋白(凝块)(凝块)XaVaPLCa2+VII凝血酶凝血酶IIaIXaVIIIaCa2+PL Xa因子的核心作用Normal hemostasis and coagulation(3)fibrin:fibrinogenthrombinfibrin monomer-polymerXIIIapolymer(4

9、)function of thrombin: coagulation:activate、 strengthen 、 platelet:aggregation, release fibrinolysis:activate plasminogenNormal hemostasis and coagulationAnticoagulant system:1. anticoagulin:(1)each coagulate factor and their complex has its own inhibitor(2)important: AT-:70% anticoagulant activity

10、serine proteinase inhibitor a. a. a. a. DKNormal hemostasis and coagulation(3)protein C system: PCTMAPC+PS sterilize Va. VIIIa. Inhibit PAIPhysiology and Pathology APCI a,trypsinize, TM+thrombin activator sterilize a,a PC APC release plasminogen Ca+ fibrolysis Ca+ PS modulate the activation of c acc

11、eleration inhibition APC:Activated Protein C Normal hemostasis and coagulationfibrinolysis:1. plasminogenplasminogen activator plasmin (PAI)()(a a2-AP)2. fibrinolysis: fibrinogenfragmentX fragmentY fragmentE (FDP)polypeptideABC fragmentD fragmentD Abnormality 1. Vessel wall: heredity:Telangiectasis

12、aquired:deficiency of Vit C、 Vit P hypersensitivity:anaphylactoid purpura else: Abnormality2. Platelet:(1)thrombocytopenia: production:AA, leukemia, infection, drug destruction :ITP exhaust:TTP、HUS、DIC Abnormality (2)thrombocythemia : primary:Primary hemorrhagic thrombocythemia secondary:CML, splene

13、ctomy , infection trauma(3)function deficiency: heredity :thrombasthenia secondary:drug, renal failure liver diseaseAbnormality 3. Coagulation:(1)heredity:hemophilia、willabrand disease(2)aquired:liver disease、renal failure、 VitK deficiency、 DIC(3)anticoagulant agents:、-Ab、drugDiagnosis History and p

14、hysical exam(PE): 1.history:cause, sex、heredity background course 2.PE:petechial bleeding (organ, muscle, joint cavity)DiagnosisLab examination: 1.filter: vessel, platelet: BT、plt、CRT coagulation:CT、APTT、PT、TTDiagnosis2.particular:(1)platelet: morphology:bulk、scatter、gathering adhesion、aggregation:

15、inducer:Adr、ADP、collagen、ristocetin thrombasthenia thrombus diseaseDiagnosis(2)Coagulation: APTT+CT:VIII. IX. XI PTCT:V. VII. X. II TT:fibrinogen、anticoagulant agents Coagulant factor test:quantity activationPrevention and Therapy1. Prevention: drug:aspirin, persantin, indomethacin disease: liver di

16、sease ,renal failure heredity:prevent traumer 、operationPrevention and Therapy2. hemostasis :(1)supplyment:coagulant factor、fresh plasma、blood、platelet(2)drug: vessel:VitC、VitP、Carbazochrome 、Pred platelet:Etamsylate 、 Pred coagulation:VitK、prothrombin complex fibrinolysis:EACA,PAMBA,Tranexamic Acid (3)local:oppression、decrease movement

展开阅读全文
相关资源
正为您匹配相似的精品文档
相关搜索

最新文档


当前位置:首页 > 高等教育 > 其它相关文档

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号